Skip to main content

Month: July 2023

FTAI Aviation Ltd. Announces Timing of Second Quarter Earnings and Conference Call

NEW YORK, July 07, 2023 (GLOBE NEWSWIRE) — FTAI Aviation Ltd. (NASDAQ: FTAI; the “Company” or “FTAI”) plans to announce its financial results for the second quarter after the closing of Nasdaq on Wednesday, July 26, 2023. A copy of the press release and an earnings supplement will be posted to the Investor Relations section of the Company’s website, https://www.ftaiaviation.com/. In addition, management will host a conference call on Thursday, July 27, 2023 at 8:00 A.M. Eastern Time. The conference call may be accessed by registering via the following link https://register.vevent.com/register/BI7cde64c0dac24e88bb4ba97051465bde. Once registered, participants will receive a dial-in and unique pin to access the call. A simultaneous webcast of the conference call will be available to the public on a listen-only basis...

Continue reading

Completion of merger of subsidiaries

According to the company announcement published by Nordecon AS on 06 April 2023, Nordecon AS started the merger of two 100% subsidiaries of the group, Tariston AS and Kaurits OÜ. AS Tariston and Kaurits OÜ signed a merger agreement on 21 April 2023, the purpose of which was to improve the internal efficiency of the group and simplify the management structure. According to the merger agreement, the merging company was AS Tariston. As a result of the merger, Kaurits OÜ ended and AS Tariston continues as the legal successor of Kaurits OÜ. The balance sheet date of the merger, from which all transactions of Kaurits OÜ are considered to have been made at the expense of AS Tariston, is 01 January 2023. The merger was entered in the Business Register on 07 July 2023 and the merger has been completed. This transaction does not have any effect...

Continue reading

Instant Insights: Clinical Decision Support System Market Set to Soar Past USD 10.7 Billion by 2030

The global Clinical Decision Support System market size is expected to reach USD 10.7 billion by 2030 and exhibit a CAGR of 10.4% in the forecast period (2023−2030), according to SyQuest’s latest research report. The increasing adoption of electronic health records, growing emphasis on improving patient outcomes, rising need for reducing medical errors and adverse events, growing prevalence of chronic diseases, and rising demand for personalized and evidence-based medicine, are fueling the market’s growth. Westford, USA, July 07, 2023 (GLOBE NEWSWIRE) — According to SyQuest’s latest global research of the Clinical Decision Support System market, increasing integration of clinical decision support systems with electronic health records, adoption of cloud-based clinical decision support solutions, incorporation of natural language...

Continue reading

Fly Play hf.: Another record month for PLAY – 83% increase in passenger numbers from last year, 87.2% load factor and 81.2% punctuality.

Another record month for PLAY – 83% increase in passenger numbers from last year, 87.2% load factor and 81.2% punctuality. PLAY carried 160,979 passengers in June, which is a new record in the airline‘s history. The number of passengers in June is nearly 25% higher compared to May when PLAY carried 128,894 passengers, which was also then an all-time high for the airline. The load factor for June was 87.2% and 81.2% of PLAY‘s flights arrived on time. Of all passengers flying with PLAY in June 2023, 29.8% were departing from Iceland, 25.8% were traveling to Iceland, and 44.4% were connecting passengers (VIA). A total of 604,670 passengers traveled with PLAY in the first six months of 2023, which is an increase of 154% from the same period in 2022 when 238,053 passengers traveled with PLAY. In the second quarter of 2023, 392,325...

Continue reading

VÍS: Áhrif af sölu eignarhluta í Kerecis

VÍS hefur samþykkt sölu á öllum eignarhlut sínum í Kerecis, sem nemur 136.715 hlutum, í tengslum við yfirtökutilboð Coloplast í félagið, en salan er háð samþykki 90% hluthafa í Kerecis.Eign VÍS í Kerecis var skráð í reikningum félagsins á genginu USD 79,18 á hlut við lok fyrsta ársfjórðungs eða sem nemur 1.4 ma.kr. Miðað við þær upplýsingar sem liggja fyrir þá er áætlað gengi í viðskiptunum um USD 150 á hlut, en getur tekið breytingum út frá ýmsum forsendum. Miðað við framangreint, er kaupvirði hlutar VÍS um 2.8 ma.kr. ef tekið er mið af skráðu gengi USD í dag. Í ljósi þessa hefur félagið uppfært virði Kerecis sem kemur inn í uppgjör á öðrum ársfjórðungi. Samkvæmt drögum að uppgjöri annars ársfjórðungs eru fjárfestingartekjur tæplega  1.3 ma.kr., að teknu tilliti til uppfærðs virðismats á Kerecis, sem gerir 3,0% nafnávöxtun. Fjárfestingartekjur...

Continue reading

27/2023 Green Hydrogen Systems – Major shareholder announcement

Company announcement 27/2023 Major shareholder announcement Kolding, Denmark, 7 July 2023 – Green Hydrogen Systems A/S (the “Company”) announces receipt of the following notifications pursuant to section 55 of the Danish Companies Act and section 30 of the Danish Capital Markets Act: As of today, ATP owns 12,690,000 shares at a nominal value of DKK 1.00 each corresponding to 6.76% of the shares and of the voting rights in the Company. For more info please contact: Investors: Jens Holm Binger, Head of Investor Relations, +45 6065 6525, jhb@greenhydrogen.dk Media: Jesper Buhl, Head of Public Affairs and Media Relations, +45 5351 5295, jbu@greenhydrogen.dk Green Hydrogen Systems in brief Green Hydrogen Systems is a clean technology company and a leading provider of standardised and modular electrolysers for the production of green hydrogen...

Continue reading

Kvika banki hf.: Moody’s confirms Kvika’s issuer- and deposit ratings; outlook stable

Moody’s Investors Service (“Moody’s”) today confirmed Kvika banki hf.’s („Kvika“) long-term and short-term deposit ratings of Baa1/P-2, the long-term issuer ratings of Baa2, and the Baseline Credit Assessment (BCA) and Adjusted BCA of ba1. Moody’s rating action concludes the review for upgrade initiated on 13 February 2023 in relation to Kvika’s merger discussions with Íslandsbanki hf., confirming Kvika’s ratings at their previous levels. Moody’s also confirmed Kvika’s long-term and short-term Counterparty Risk Ratings of Baa1/P-2 and the long-term and short-term Counterparty Risk Assessments of Baa1(cr)/P-2(cr). The outlook on the long-term deposit and issuer ratings has been changed to stable from ratings under review for upgrade. For further information please contact Kvika‘s investor relations at ir@kvika.is or via tel. (+354)...

Continue reading

Coloplast A/S – Announcement no. 03/2023 – Coloplast announces agreement to acquire Kerecis and raises long-term growth expectations

Coloplast has signed an agreement to acquire Kerecis, an innovative, fast-growing company in the biologics wound care segment, for up to USD 1.3 billion (around DKK 8.9 billion), of which USD 1.2 billion (around DKK 8.2 billion) is an upfront cash paymentKerecis represents an attractive opportunity to strategically strengthen Coloplast’s presence in the advanced wound care market by entering the high-growth, US-centric biologics segment With a mission to improve wound care treatment, Kerecis has developed and patented a clinically differentiated, sustainable, and scalable technology platform based on intact fish skin Produced with minimal processing, the fish skin retains its similarity to human skin, resulting in improved wound healing. The technology is backed by compelling evidence from multiple clinical trials and has already...

Continue reading

Sampo plc’s share buybacks 06/07/2023

SAMPO PLC                 STOCK EXCHANGE RELEASE         07/07/2023 at 08:30 am Sampo plc’s share buybacks 06/07/2023 On 06/07/2023 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  5,570 40.45 AQEU  33,901 40.37 CEUX  9,729 40.41 TQEX  70,800 40.35 XHELTOTAL 120,000 40.36  *rounded to two decimals                 On 29 March 2023, Sampo announced a share buyback programme of up to a maximum of EUR 400 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 3 April 2023, is...

Continue reading

Edf: Electricité de France Announces the Final Results of its Tender Offer as of the Expiration Date

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. THIS ANNOUNCEMENT IS FOR INFORMATION ONLY AND IS NOT AN OFFER TO PURCHASE OR A SOLICITATION OF OFFERS TO SELL ANY SECURITIES. THE TENDER OFFER IS BEING MADE ONLY PURSUANT TO THE OFFER TO PURCHASE AND ONLY IN SUCH JURISDICTIONS AS IS PERMITTED UNDER APPLICABLE LAW. Paris, July 7, 2023 Electricité de France Announces the Final Results of its Tender Offer as of the Expiration Date Electricité de France (the “Company”) hereby announces the final results of its offer to purchase for cash any and all (the “Offer”) of its $1,500,000,000 Reset Perpetual Subordinated Notes (the “Notes”), which are admitted to trading on the regulated market of the Luxembourg Stock Exchange, as of 5:00 p.m., New...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.